Scrip Dividend - calculation price
Reading, United Kingdom (12 April 2018)
On 13 February 2018, the Board of Directors of ConvaTec Group Plc ("ConvaTec" or "the Company") proposed a final dividend in respect of 2017 subject to shareholder approval at the Annual General Meeting on 10 May 2018 of 4.3 cents per share (the "final dividend"). This final dividend is to be paid on 17 May 2018 to shareholders on the share register as at 6 April 2018. The dividend is payable in cash in Sterling to holders of ordinary shares. On 15 February 2018, the Company announced that a Scrip Dividend Scheme will be made available for this final dividend allowing shareholders to elect to receive their dividend in the form of new ordinary shares.
The "Calculation Price" for the issue of new ordinary shares under the Scrip Dividend Scheme is:
202.62 pence for each new ordinary share
This is equivalent to 1 new share for approximately 65.36 shares held prior to the ex-dividend date of 5 April 2018
The Calculation Price is the average of the middle market quotations of a ConvaTec share, derived from the London Stock Exchange Daily Official List, for the five consecutive business days from 5 April to 11 April 2018 (inclusive).
The latest date for receipt of elections to participate in the Scrip Dividend Scheme for this final dividend is 20 April 2018. Shareholders must return their mandate form by 5pm (GMT) or otherwise input their CREST elections to be received by the Company's registrar, Computershare, by 3pm (GMT) on 20 April 2018. Elections received after this deadline will apply to subsequent dividends only. Unless revoked by you, your scrip dividend election will apply for all future dividends for which a scrip dividend is offered. Evergreen elections for CREST shareholders cannot be accepted and elections will revert to cash by default after the payment of each dividend.
Details of the Scrip Dividend Scheme are available at www.convatecgroup.com/investors
TIMETABLE
Key dates in respect of the Scrip Dividend Scheme for the final dividend are:
Ex-dividend Date |
5 April 2018 |
Record Date |
6 April 2018 |
Scrip calculation price determined |
5-11 April 2018 (inclusive) |
Scrip calculation price available and announced |
12 April 2018 |
Mandate delivery deadline for Shares held in uncertificated form |
3.00 p.m. on 20 April 2018 |
Mandate delivery deadline for Shares held in certificated form |
5.00 p.m. on 20 April 2018 |
Announcement of the total amount of new shares to be issued |
26 April 2018 |
Dividend payment date |
17 May 2018 |
Dispatch of statement in accordance with section 7 of Scheme Rules and share certificates, CREST accounts credited/updated, and first day of dealings in New Shares |
17 May 2018 |
Enquiries
Media
Bobby Leach, VP Group Corporate Affairs, ConvaTec +44 (0)7770 842 226
Alastair Elwen, Finsbury +44 (0)207 251 3801
Analysts and Investors
John Crosse, VP Investor Relations, ConvaTec +44 (0)7500 141 435
Kirsty Law, Director Investor Relations, ConvaTec +44 (0)7470 909 582
investorrelations@convatec.com
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.
# # #